About Us

Research Approach Pipeline The Team Resource Library Careers● We're Hiring

Therapeutic Focus

Glanzmann Thrombasthenia Von Willebrand Disease FVII Deficiency Clinical Trials

For Patients & Caregivers

Therapeutic Focus Clinical Trials Connect with Patient Advocacy

For Healthcare Providers

Research Approach Pipeline Clinical Trials Connect with Medical

All News and Media

ISTH 2026: Sutacimig Prophylaxis in Glanzmann Thrombasthenia: Results from a Phase 2 Long-Term Extension

July 14, 2026

July 14, 2026

To view the presentation, click here

Hemab

About Us Therapeutic Focus For Patients & Caregivers For Healthcare Providers Contact Us

Therapeutic Focus

Glanzmann Thrombasthenia Von Willebrand Disease Clinical Trials Pipeline Research Approach

About

Resource Library Meet the Team Join our Team

Investors

Investor Relations Site

Contact Us

Connect with Patient Advocacy Connect with Medical Connect with General Inquiries Connect with Clinical Trials

Linkedin Instagram X Privacy and Cookie Policy Clinical Trial Privacy Notice Cookie Settings Terms of Use Expanded Access Policy

Hemab Therapeutics Holdings, Inc. 2026. All rights reserved.